Skip to main content
. 2023 Aug 11;3:1204207. doi: 10.3389/frhs.2023.1204207

Table 5.

Preference values assessed by participants, criterion weights the right column, and the weighted preference values in the bottom row and the sum of the weights. (Step 2 and Phase 3 of the prioritisation process, which included decision conferencing).

MHC BAME PhysChks IAPT svcs MHCaccLT CaregvrSup InCrSubAb Emplmnt PeerSupp HrmPrbsA Weiwei
Clinically effective 70 100 100 90 50 70 30 0 20 21.5
Patients involved 100 0 80 20 90 70 65 100 10 16.7
Reduces inequalities 100 81 0 25 38 50 25 13 100 19.0
Implementable 100 50 70 80 70 0 20 70 30 23.8
Sustainable 70 100 70 80 0 20 30 0 20 19.0
Total 88 68 65 62 50 40 33 36 36 100